Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
Part of paid clinical trials in Scottsdale, Arizona.
- Sponsor
- Proton Collaborative Group
- Study ID
- NCT01766297
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Breast Cancer
- Breast Neoplasm
- Breast Tumor
- Cancer of the Breast
Eligibility Criteria
- Sex
- FEMALE
- Age
- 50 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Proton Radiotherapy — RADIATION
Study Details
The purpose of this research study is to compare the effects (good and bad) on women and their cancer using proton radiation therapy. This study is being done to see if proton radiation therapy will prove to be beneficial for women with early stage breast cancer. A clinical study is necessary to compare the results (good or bad) of proton radiation therapy.
Key Dates
- Start date
- Feb 28, 2013
- Status verified
- Sep 2025
- Primary completion
- Jan 31, 2027
- Completion
- Jan 31, 2035
Study Design
- Enrollment
- 132 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Proton RadiotherapyProton Radiotherapy 4.0 Gy (RBE) x10 fractions to 40 Gy (RBE) Total Dose
Primary Outcome Measure
To assess events of freedom from ipsilateral breast recurrence occurrences in patients receiving partial breast proton radiation therapy limited to the region of the tumor. [ Time Frame: At 3 years ]
Locations (9)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic | Scottsdale | Arizona | 85259 | Carlos Vargas, MD (PRINCIPAL_INVESTIGATOR) |
| California Protons Cancer Therapy Center | San Diego | California | 92121 | James Urbanic, MD (PRINCIPAL_INVESTIGATOR) |
| Northwestern Medicine Chicago Proton Center | Warrenville | Illinois | 60555 | Arpi Thukral, MD (PRINCIPAL_INVESTIGATOR) |
| Maryland Proton Treatment Center | Baltimore | Maryland | 21201 | Elizabeth Nichols, MD (PRINCIPAL_INVESTIGATOR) |
| McLaren Proton Therapy Center | Flint | Michigan | 48532 | Brian Yeh, MD (PRINCIPAL_INVESTIGATOR) |
| New York Proton Center | New York | New York | 10035 | Isabelle Choi, MD (PRINCIPAL_INVESTIGATOR) |
| Oklahoma Proton Center | Oklahoma City | Oklahoma | 73142 | John Chang, MD (PRINCIPAL_INVESTIGATOR) |
| Inova Schar Cancer Institute | Fairfax | Virginia | 22031 | Ashish Chawla, MD (PRINCIPAL_INVESTIGATOR) |
| Hampton University Proton Therapy Institute | Hampton | Virginia | 23666 | Christopher Sinesi, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Scottsdale, AZ
By condition
By specialty
Related Studies
- Collection of Blood From Patients With CancerRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Harvesting Cells for Experimental Cancer TreatmentsEnrolling By Invitation · National Cancer Institute (NCI) · Bethesda, Maryland
- Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer StudiesRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA MutationsRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey